Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

By the year 2020, cardiovascular disease will be the world's biggest cause of premature death. As the plasma cholesterol is lowered, the incidence of coronary heart disease (CHD) events is reduced. European data on secondary prevention show that many patients have not had a plasma cholesterol recorded - even those with a diagnosis of CHD. English data show that only half of patients with a cholesterol measurement are being prescribed a statin, and only half of those are being treated to target. Poor public understanding of this subject area is one obstacle to progress.

Type

Journal article

Journal

British Journal of Diabetes and Vascular Disease

Publication Date

01/01/2004

Volume

4